.After rearing $213 thousand in 2023-- one of the year's most extensive private biotech rounds-- Vol...
.Welcome to today's Chutes & Ladders, our roundup of significant management hirings, firings as w...
.Venture capital backing into biopharma cheered $9.2 billion throughout 215 sell the second one-four...
.Bicara Therapeutics and also Zenas Biopharma have actually delivered new impetus to the IPO market ...
.Genentech will definitely shut its cancer cells immunology research study department, and unit mind...
.Kezar Lifestyle Sciences is falling its unpromising stage 1 solid cyst drug as the biotech goes all...
.Even with izokibep keeping its own newly found winning touch in the center, Acelyrin is actually no...
.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...
.Ovid Therapeutics actually disclosed final month that it was trimming its own head count as the fir...
.Eli Lilly has actually opened a $700 million R&D center in the Boston Seaport, boosting its RNA ...